Novartis to Acquire Control of Alcon Inc.

by Astrid Fiano, DOTmed News Writer | January 06, 2010

Some of Alcon's products include: ACRYSOF® intraocular lenses, PATANOL® /OPATANOL® solution. CIPRODEX® Otic suspension and the OPTI-FREE® solution line.

Some of Novartis' products include: Influenza, polio, meningitis and rabies vaccines, Air Optix contact lenses, FreshLook color contact lenses, Dailies disposable lenses, Bufferin, Excedrin, Keri, Maalox, Theraflu and Triaminic.

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

On Nestle's website, Peter Brabeck-Letmathe, Chairman of Nestle S.A., stated, "Over the years Nestle's financial and operational support has allowed Alcon's management to focus on its fantastic development from a minor player to global leadership in the ophthalmologic business. I would like to thank the managements of both Alcon and Nestle for their work in building such a successful business and I am sure that with Novartis we have found the right partner for Alcon's promising future."

Adapted in part from Novartis, Alcon and Nestle press releases.

Novartis press release: http://www.novartis.com/downloads/investors/presentations-events/other-events/2010/20100104-alcon-media-release_EN.pdf

Alcon press release: http://invest.alconinc.com/phoenix.zhtml?c=130946&p=irol-pressReleasesArticle&ID=1370089&highlight=

Nestle press release: http://www.nestle.com/MediaCenter/PressReleases/AllPressReleases/Alcon.htm

Back to HCB News